News tagged with cancer therapeutics
When It Comes to Drug Delivery, Size Matters
Nanotechnology / Bio & Medicine
Nov 20, 2009 |
5 / 5 (2) |
0
(PhysOrg.com) -- One of the great promises of nanotechnologies lies in its ability to create drug-containing nanoparticles decorated with targeting molecules that recognize and bind to cancer cells, providing drug delivery ...
Common pain relief medication may encourage cancer growth
Nov 18, 2009 |
5 / 5 (3) |
0
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of ...
Enzyme inhibitor takes an unexpected approach toward blocking cancer-promoting protein
Sep 08, 2009 |
not rated yet |
0
Scientists at Fox Chase Cancer Center have discovered a unique method of attack that may be used to inhibit signaling enzymes called kinases, which often have a role in sustaining drug-resistant cancerous cells. They have ...
MIT student develops new innovations to selectively kill cancer cells
Nanotechnology / Bio & Medicine
Mar 03, 2009 |
4.9 / 5 (15) |
5
When it comes to solving complex problems, Geoffrey von Maltzahn, MIT graduate student and biomedical engineer, looks to nature for solutions. Finding inspiration in systems that evolution has produced, von ...
Search results for cancer therapeutics
Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis
Nov 25, 2009 |
not rated yet |
0
Two signaling pathways essential to normal human development - the Wnt/Wingless (Wnt) and epidermal growth factor receptor (EGFR) pathways - interact in ways that can promote tumor cell invasion and metastasis, researchers ...
Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer
Nov 22, 2009 |
not rated yet |
0
Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. This breakthrough ...
Promising pharmaceutical agents emerge as sports doping products
Medicine & Health / Medications
Nov 19, 2009 |
not rated yet |
0
Researchers from the German Sport University Cologne in Germany found that non-steroidal and tissue-selective anabolic agents such as Selective Androgen Receptor Modulators (SARMs) are being sold on the black market for their ...
Detecting the Undetectable in Prostate Cancer Testing
Nanotechnology / Bio & Medicine
Nov 18, 2009 |
4 / 5 (1) |
1
(PhysOrg.com) -- A team of Northwestern University researchers, using an extremely sensitive nanotechnology-based tool known as the biobarcode system, has detected previously undetectable levels of prostate-specific antigen ...
World's first delivery of intra-arterial Avastin directly into brain tumor
Nov 17, 2009 |
5 / 5 (1) |
0
Neurosurgeons from NewYork-Presbyterian Hospital/Weill Cornell Medical Center performed the world's first intra-arterial cerebral infusion of Avastin (bevacizumab) directly into a patient's malignant brain tumor. This novel ...
New combination therapy could deliver powerful punch to breast cancer
Nov 16, 2009 |
not rated yet |
0
A powerful new breast cancer treatment could result from packaging one of the newer drugs that inhibits cancer's hallmark wild growth with another that blocks a primordial survival technique in which the cancer ...
Novel mouse gene reduces major pathologies associated with Alzheimer's disease
Medicine & Health / Neuroscience
Nov 11, 2009 |
3.8 / 5 (4) |
0
A new study reveals that a previously undiscovered mouse gene reduces the two major pathological perturbations commonly associated with Alzheimer's disease (AD). The research, published by Cell Press in the November 12 issue ...
Discovery offers potential new pancreatic cancer treatment
Nov 02, 2009 |
3 / 5 (1) |
1
Tiny particles that can carry drugs and target cancer cells may offer treatment hope for those suffering with pancreatic cancer. New research to be presented in November at the American Association of Pharmaceutical Scientists ...
Inhibitor of Heat Shock Protein is a Potential Anticancer Drug, Study Finds
Oct 29, 2009 |
not rated yet |
0
(PhysOrg.com) -- Like yoga for office drones, cells do have coping strategies for stress. Heat, lack of nutrients, oxygen radicals - all can wreak havoc on the delicate internal components of a cell, potentially ...
Centralized Review Process Markedly Expedites Approval of Cancer Clinical Trials
Oct 19, 2009 |
not rated yet |
0
(PhysOrg.com) -- A Central Institutional Review Board (CIRB) for cancer clinical trials that was created by the National Cancer Institute (NCI), part of the National Institutes of Health, in 2001 helps trials start more quickly ...
List of search results for cancer therapeutics
